The primary aim of this project was to decrease the overutilization of HFNC therapy in the treatment of healthy infants with bronchiolitis 30 days to 23 months of age. We aimed to accomplish this through implementation of standard HFNC initiation and weaning interventions. We hypothesized that participating institutions would decrease the proportion of children with bronchiolitis who are treated with HFNC and decrease the total HFNC duration of therapy without an associated increase in ED length of stay (LOS) or total hospital LOS. 

Key Drivers

Key drivers are broad, evidence-based actions that can be useful in the development of more specific ideas for changes that lead to improvement. The tools and resources associated with these key drivers are meant to be adapted or adopted in your healtyhcare setting to improve immunization processes.

Learn More

Measurement Strategy

The measures set that was developed in the HIFLO Project are for reference, adaptation and use in your practice.

Learn More


Blurb about how the project is ongoing (list end date)?  Manuscripts are currently in development for this project, check back to see project results when they've been published.

Project Background

Learn more about the background and development of the HIFLO project here.

Acknowledgements and Contributors

We would like to extend our special thanks to the individuals and organizations for their assistance in the development and provision of resources included in this change package.